Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients
Jérôme Hadjadj, Nader Yatim, Laura Barnabei, Aurélien Corneau, Jeremy Boussier, Hélène Péré, Bruno Charbit, Vincent Bondet, Camille Chenevier-Gobeaux, Paul Breillat, Nicolas Carlier, Rémy Gauzit, Caroline Morbieu, Frédéric Pène, Nathalie Marin, Nicolas Roche, Tali-Anne Szwebel, Nikaïa Smith, Sarah H Merkling, Jean-Marc Treluyer, David Verer, Luc Mouthon, Catherine Blanc, Pierre-Louis Tharaux, Flore Rozenberg, Alain Fischer, Darragh Duffy, Frédéric Rieux-Laucat, Solen Kernéis, Benjamin Terrier
doi: https://doi.org/10.1101/2020.04.19.20068015
Jérôme Hadjadj
1Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, Université de Paris, F-75015, Paris
2Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Université de Paris, F-75014, Paris
Nader Yatim
3Laboratory of Dendritic Cell Immunobiology, Department of Immunology, Institut Pasteur, F-75015, Paris
Laura Barnabei
1Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, Université de Paris, F-75015, Paris
Aurélien Corneau
4Sorbonne Université, Faculté de médecine, UMS037, PASS, Plateforme de cytométrie de la Pitié-Salpêtrière CyPS, F-75013, Paris
Jeremy Boussier
3Laboratory of Dendritic Cell Immunobiology, Department of Immunology, Institut Pasteur, F-75015, Paris
Hélène Péré
5Department of Virology, APHP-CUP, Université de Paris, F-75015, Paris
6PARCC, INSERM U970, Paris
Bruno Charbit
7Centre for Translational Research, Institut Pasteur, F-75015, Paris
Vincent Bondet
3Laboratory of Dendritic Cell Immunobiology, Department of Immunology, Institut Pasteur, F-75015, Paris
Camille Chenevier-Gobeaux
8Department of Automated Diagnostic Biology, APHP.Centre-Université de Paris, F-75014
Paul Breillat
2Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Université de Paris, F-75014, Paris
Nicolas Carlier
9Department of Pulmonology, APHP-CUP, Institut Cochin, UMR 1016, CESP U1018, Université de Paris, F-75014, Paris
Rémy Gauzit
10Equipe Mobile d’Infectiologie, APHP Centre-Université de Paris, F-75014, Paris
Caroline Morbieu
2Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Université de Paris, F-75014, Paris
Frédéric Pène
11Medical intensive care unit, APHP-CUP, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, F-75014, Paris
Nathalie Marin
11Medical intensive care unit, APHP-CUP, Institut Cochin, INSERM U1016, CNRS UMR 8104, Université de Paris, F-75014, Paris
Nicolas Roche
8Department of Automated Diagnostic Biology, APHP.Centre-Université de Paris, F-75014
Tali-Anne Szwebel
2Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Université de Paris, F-75014, Paris
Nikaïa Smith
3Laboratory of Dendritic Cell Immunobiology, Department of Immunology, Institut Pasteur, F-75015, Paris
Sarah H Merkling
12Insect-Virus Interactions Unit, Institut Pasteur, UMR2000, CNRS, Paris
Jean-Marc Treluyer
13Centre Régional de Pharmacovigilance, APHP-CUP, Université de Paris, F-75014, Paris
David Verer
5Department of Virology, APHP-CUP, Université de Paris, F-75015, Paris
Luc Mouthon
2Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Université de Paris, F-75014, Paris
Catherine Blanc
4Sorbonne Université, Faculté de médecine, UMS037, PASS, Plateforme de cytométrie de la Pitié-Salpêtrière CyPS, F-75013, Paris
Pierre-Louis Tharaux
6PARCC, INSERM U970, Paris
Flore Rozenberg
14Department of Virology, APHP-CUP, Université de Paris, F-75014, Paris
Alain Fischer
1Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, Université de Paris, F-75015, Paris
15Unité d’immunologie hématologie et rhumatologie pédiatriques, APHP-CUP, Université de Paris, F-75015, Paris
16Collège de France, Paris
Darragh Duffy
3Laboratory of Dendritic Cell Immunobiology, Department of Immunology, Institut Pasteur, F-75015, Paris
7Centre for Translational Research, Institut Pasteur, F-75015, Paris
Frédéric Rieux-Laucat
1Imagine institute, laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, Université de Paris, F-75015, Paris
Solen Kernéis
10Equipe Mobile d’Infectiologie, APHP Centre-Université de Paris, F-75014, Paris
17Epidémiologie et modélisation de la résistance aux antimicrobiens, Institut Pasteur, F-75015, Paris, France
Benjamin Terrier
2Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Assistance Publique Hôpitaux de Paris-Centre (APHP-CUP), Université de Paris, F-75014, Paris
6PARCC, INSERM U970, Paris
Posted April 23, 2020.
Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients
Jérôme Hadjadj, Nader Yatim, Laura Barnabei, Aurélien Corneau, Jeremy Boussier, Hélène Péré, Bruno Charbit, Vincent Bondet, Camille Chenevier-Gobeaux, Paul Breillat, Nicolas Carlier, Rémy Gauzit, Caroline Morbieu, Frédéric Pène, Nathalie Marin, Nicolas Roche, Tali-Anne Szwebel, Nikaïa Smith, Sarah H Merkling, Jean-Marc Treluyer, David Verer, Luc Mouthon, Catherine Blanc, Pierre-Louis Tharaux, Flore Rozenberg, Alain Fischer, Darragh Duffy, Frédéric Rieux-Laucat, Solen Kernéis, Benjamin Terrier
medRxiv 2020.04.19.20068015; doi: https://doi.org/10.1101/2020.04.19.20068015
Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients
Jérôme Hadjadj, Nader Yatim, Laura Barnabei, Aurélien Corneau, Jeremy Boussier, Hélène Péré, Bruno Charbit, Vincent Bondet, Camille Chenevier-Gobeaux, Paul Breillat, Nicolas Carlier, Rémy Gauzit, Caroline Morbieu, Frédéric Pène, Nathalie Marin, Nicolas Roche, Tali-Anne Szwebel, Nikaïa Smith, Sarah H Merkling, Jean-Marc Treluyer, David Verer, Luc Mouthon, Catherine Blanc, Pierre-Louis Tharaux, Flore Rozenberg, Alain Fischer, Darragh Duffy, Frédéric Rieux-Laucat, Solen Kernéis, Benjamin Terrier
medRxiv 2020.04.19.20068015; doi: https://doi.org/10.1101/2020.04.19.20068015
Subject Area
Subject Areas
- Addiction Medicine (365)
- Allergy and Immunology (685)
- Anesthesia (183)
- Cardiovascular Medicine (2724)
- Dermatology (234)
- Emergency Medicine (411)
- Epidemiology (12378)
- Forensic Medicine (10)
- Gastroenterology (783)
- Genetic and Genomic Medicine (4233)
- Geriatric Medicine (394)
- Health Economics (698)
- Health Informatics (2732)
- Health Policy (1014)
- Hematology (369)
- HIV/AIDS (874)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (450)
- Neurology (4010)
- Nursing (216)
- Nutrition (594)
- Oncology (2112)
- Ophthalmology (602)
- Orthopedics (251)
- Otolaryngology (310)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (475)
- Pediatrics (1145)
- Primary Care Research (465)
- Public and Global Health (6630)
- Radiology and Imaging (1440)
- Respiratory Medicine (883)
- Rheumatology (418)
- Sports Medicine (350)
- Surgery (461)
- Toxicology (57)
- Transplantation (192)
- Urology (171)